Read this article:
S&P 500 has stunk, especially compared to these funds
See which stocks are being affected by Social Media
[…]
On March 30, 2014 GeoInvesting stated that it was taking a closer look at Great Basin Scientific (GBSN) as just 3 months after the company went public on October 9, 2014, we received a promotional pump, e-mail newsletter. The day of its IPO, GBSN reached an intraday trading high of $9.08 before closing at $5.97. Since its IPO and until recently, GBSN […]
Source: Flickr user Mike PoreskyFew sectors offer a greater potential for risk and reward than biotechnology. It’s a sector where many companies are still in the early stages of their drug development process, but if you happen to catch a winner the returns can compound many times over.Unfortunately, the odds are stacked against biotech investors with far more drugs failing […]
Read the article:
Is that Investment Really “On Sale”?
See which stocks are being affected by Social Media
[…]
Once again, acquisition news made it to the headlines with Horizon Pharma (HZNP – Snapshot Report) announcing that it will be acquiring Hyperion Therapeutics (HPTX – Snapshot Report). BioMarin has hit a 52-week high on acquisition rumors. Meanwhile, it’s been an eventful week on the pipeline and regulatory front as well with companies like Conatus (CNAT – Snapshot Report), Amgen […]
Source article:
Sarepta shares rally 10% as company names interim CEO
See which stocks are being affected by Social Media
[…]
See original article here:
Biotech ETFs in Focus after a Choppy Week – ETF News And Commentary
[…]
Since reaching all-time highs on March 19, the three largest biotech exchange traded funds are off 4.4% with the SPDR S&P Biotech ETF (XBI) ranking as the worst offender of the trio with a loss of 5.7%.XBI’s recent struggles illustrate the ETF’s risk/reward proposition. As an equal-weight ETF, the $2.1 billion XBI is dependent on the largest biotech stocks, such […]
Visit site:
Momentum Stocks: Caution Ahead
See which stocks are being affected by Social Media
[…]
This Weekend my eyes and thoughts curved around the Healthcare sector. I read several interesting articles from the sector, mostly about the biotech’s and new Hepatitis C drugs from Gilead, Sovaldi and Harvoni.Those are very expensive drugs with potential to kill the current medical systems but they also generate tons of cash for their corporate.I also noticed that the Healthcare […]
